Meta‐analysis: inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease von VAN DIEREN, J. M., HANSEN, B. E., KUIPERS, E. J., NIEUWENHUIS, E. E. S., VAN DER WOUDE, C. J.

Volltext

Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer von van der Kaaij, R. T., van Kessel, J. P., van Dieren, J. M., Snaebjornsson, P., Balagué, O., van Coevorden, F., van der Kolk, L. E., Sikorska, K., Cats, A., van Sandick, J. W.

Volltext

Pharmacogenetics of thiopurine therapy in paediatric IBD patients von RIDDER, L., DIEREN, J. M., DEVENTER, H. J. H., STOKKERS, P. C. F., WOUDE, J. C. J., VUUREN, A. J., BENNINGA, M. A., ESCHER, J. C., HOMMES, D. W.

Volltext

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts von Berbée, M., Muijs, C.T., Voncken, F.E.M., Wee, L., Sosef, M., van Etten, B., van Sandick, J.W., Warmerdam, F.A.R.M., de Haan, J.J., Oldehinkel, E., van Dieren, J.M., Boersma, L., Langendijk, J.A., van der Schaaf, A., Reitsma, J.B., Schuit, E.

Volltext

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study von Borggreve, A S, Mook, S, Verheij, M, Mul, V E M, Bergman, J J, Bartels-Rutten, A, Ter Beek, L C, Beets-Tan, R G H, Bennink, R J, van Berge Henegouwen, M I, Brosens, L A A, Defize, I L, van Dieren, J M, Dijkstra, H, van Hillegersberg, R, Hulshof, M C, van Laarhoven, H W M, Lam, M G E H, van Lier, A L H M W, Muijs, C T, Nagengast, W B, Nederveen, A J, Noordzij, W, Plukker, J T M, van Rossum, P S N, Ruurda, J P, van Sandick, J W, Weusten, B L A M, Voncken, F E M, Yakar, D, Meijer, G J

Volltext

The clinical implications of staging laparoscopy in the diagnostic workup of gastric cancer patients: A population based study von van der Sluis, K., Vollebergh, M.A., Kodach, L.L., van Dieren, J.M., de Hingh, I.H.J.T., Wijnhoven, B.P.L., Verhoeven, R.H.A., Sandick, J.W. van

Volltext

Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review von van der Sluis, L, van Dieren, J M, van der Post, R S, Bisseling, T M

Volltext

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer von Vollenbrock, S. E., Voncken, F. E. M., van Dieren, J. M., Lambregts, D. M. J., Maas, M., Meijer, G. J., Goense, L., Mook, S., Hartemink, K. J., Snaebjornsson, P., ter Beek, L. C., Verheij, M., Aleman, B. M. P., Beets‐Tan, R. G. H., Bartels‐Rutten, A.

Volltext

ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients von van Dieren, J M, van Vuuren, A J, Kusters, J G, Nieuwenhuis, E E S, Kuipers, E J, van der Woude, C J

Volltext

Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD von van Dieren, Jolanda M., Kuipers, Ernst J., Samsom, Janneke N., Nieuwenhuis, Edward E., van der Woude, C. Janneke

Volltext

O106 A CHEMORADIOTHERAPY TREATMENT RESPONSE MRNA SIGNATURE AS PREDICTOR FOR ESOPHAGEAL ADENOCARCINOMA TREATED ACCORDING TO THE CROSS REGIMEN von Hoefnagel, S J M, Koster, J, Koemans, W J, van Dieren, J M, van Sandick, J W, Kodach, L L, Calpe, S, Meijer, S L, del Sancho-Serra, C M, Khan, H N, Van Laarhoven, H W M, Van Berge Henegouwen, M I, Gisbertz, S S, Hulshof, M C C M, Krishnadath, K K

Volltext

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study von Borggreve, A. S, Mook, S, Verheij, M, Mul, V. E.M, Bergman, J. J, Bartels-Rutten, A, Ter Beek, L. C, Beets-Tan, R. G.H, Bennink, R. J, Van Berge Henegouwen, M. I, Brosens, L. A.A, Defize, I. L, Van Dieren, J. M, Dijkstra, H, Van Hillegersberg, R, Hulshof, M. C, Van Laarhoven, H. W.M, Lam, M. G.E.H, Van Lier, A. L.H.M.W, Muijs, C. T, Nagengast, W. B, Nederveen, A. J, Noordzij, W, Plukker, J. T.M, Van Rossum, P. S.N, Ruurda, J. P, Van Sandick, J. W, Weusten, B. L.A.M, Voncken, F. E.M, Yakar, D, Meijer, G. J, Aleman, B. M.P, Borra, R. J.H, Van Etten, B, Gisbertz, S. S, Goense, L, Haj Mohammad, N, Hartemink, K. J, Kappert, P, Kats-Ugurlu, G, Kodach, L. L, Korteweg, T, Krishnadath, K. K, Langendijk, J. A, De Leng, W. W.J, Meijer, S. L, Potze, J. H, Stoker, J, Vegt, E, Verkooijen, H. M, Vollenbrock, S. E, Wessels, F

Volltext

Local Immune Regulation of Mucosal Inflammation by Tacrolimus von van Dieren, Jolanda M, Lambers, Margaretha E. H, Kuipers, Ernst J, Samsom, Janneke N, van der Woude, C. Janneke, Nieuwenhuis, Edward E. S

Volltext

Authors' reply von van Dieren, J M, van Vuuren, A J, Kuipers, E J, Hansen, B E, Kusters, J G, Nieuwenhuis, E E S, van der Woude, C J

Volltext

CONTRIBUTION OF THE MUCOSAL IMMUNE SYSTEM TO METHOTREXATE INDUCED INTESTINAL DAMAGE: PG2-09 von De Koning, B AE, Lindenbergh-Kortleve, D J, Van Dieren, J M, Matsumoto, T, Pieters, R, Einerhand, A WC, Samsom, J N, Nieuwenhuis, E

Volltext

CONTRIBUTION OF THE MUCOSAL IMMUNE SYSTEM TO METHOTREXATE INDUCED INTESTINAL DAMAGE: PG2‐09 von De Koning, B AE, Lindenbergh‐Kortleve, D J, Van Dieren, J M, Matsumoto, T, Pieters, R, Einerhand, A WC, Samsom, J N, Nieuwenhuis, E

Volltext

CONTRIBUTION OF THE MUCOSAL IMMUNE SYSTEM TO METHOTREXATE INDUCED INTESTINAL DAMAGE von De Koning, B AE, Lindenbergh‐Kortleve, D J, Van Dieren, J M, Matsumoto, T, Pieters, R, Einerhand, A WC, Samsom, J N, Nieuwenhuis, E

Volltext

Heterozygous polymorphisms in the genes encoding ITPA and TPMT3A are not predictive for the development of adverse effects of Azathioprine treatment in IBD patients von van Dieren, JM, van Vuuren, AJ, Kuipers, EJ, Kusters, JG, Nieuwenhuis, EE, van der Woude, CJ

Volltext

Colonic application of tacrolimus inhibits local mucosal immune responses in mice von van Dieren, JM, van der Woude, CJ, Kuipers, EJ, Samsom, JN, Nieuwenhuis, E.E.S

Volltext

Possible mechanism of action of tacrolimus in IBD: inhibition of NKT cell- and intestinal epithelial cell-activation von van Dieren, JM, van der Woude, CJ, Lambers, MEH, Kuipers, EJ, Nieuwenhuis, EE

Volltext